Christopher Wilson is a senior associate in Baker Botts' Antitrust and Competition Practice group. His practice focuses on civil antitrust, intellectual property, and other complex commercial actions. Mr. Wilson has extensive experience in representing litigants from complaint filing through trial, as well as in advising corporate clients on a variety of antitrust matters, particularly with respect to parent/subsidiary issues, resale price maintenance, the Robinson-Patman Act, and compliance matters. He has represented and advised clients in a number of industries, including industrial manufacturing, telecommunications, pharmaceuticals, retail, and healthcare manufacturing.

Mr. Wilson has been a key member of legal teams for Fortune 500 clients defending against Sherman Act class action claims, including in cases that were granted favorable judgments at the motion to dismiss and summary judgment stages. He also has extensive experience defending pharmaceutical companies in patent infringement and antitrust actions, as well as representing generic pharmaceutical manufacturers in Hatch-Waxman Act litigation. In each of these cases, Mr. Wilson was deeply involved in setting case strategy, preparing dispositive and other critical filings, managing discovery, taking depositions and negotiating with opposing counsel.